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A B S T R A C T
Phthalates and phenolic substances were investigated in urine samples from ﬁrst-time mothers in Uppsala,
Sweden, collected between 2009 and 2014. These substances have a comparably fast metabolism and urinary
metabolites are predominantly analysed. The main aim was to investigate if measures to decrease production
and use of certain phthalates and bisphenol A (BPA) have resulted in decreased human exposure, and to
determine if exposures to replacement chemicals have increased. Temporal trends were evaluated for
metabolites (n=13) of seven phthalates, a phthalate replacer, four diﬀerent bisphenols, triclosan, one
organophosphate-based ﬂame retardant, and for two pesticides. The results showed downward trends of
several phthalates which are in the process of being regulated and phased out. Concomitantly, an increasing
trend was seen for a metabolite of the phthalate replacer Di-iso-nonylcyclohexane 1,2-dicarboxylate (DiNCH).
Bisphenol A (BPA) showed a downward trend, whereas bisphenol F, identiﬁed as one of the substitutes for BPA,
showed an increasing trend. The decreasing trend of triclosan is likely due to declining use within the EU.
Temporal trend studies of urine samples make it possible to investigate human exposure to rapidly metabolised
substances and study how measures taken to regulate and replace problematic chemicals aﬀect human
exposure.
1. Introduction
Urine samples can be used for evaluation of temporal trends of non-
persistent, rapidly metabolised, contaminants excreted in urine, such
as phthalates and bisphenols (Koch and Calafat, 2009; Johns et al.,
2015). Many of these widely used industrial chemicals have been
identiﬁed as potential endocrine disrupters (Gray et al., 2000; Nagao
et al., 2001; Borch et al., 2006; Maﬃni et al., 2006; Lyche et al., 2009;
Dann and Hontela, 2011), and there is currently a concern that human
exposure to some of these chemicals is high enough to aﬀect human
health (Jönsson et al., 2005; Dann and Hontela, 2011; Braun et al.,
2013; Chen et al., 2013; Rochester, 2013; Marie et al., 2015).
Phthalates are widely used in industrial and consumer products as
plasticizers, solvents and additives, and are commonly found in the
human environment (Net et al., 2015). Production and use of some
phthalates are currently being phased out, among them di-2-ethylhexyl
pthtalate (DEHP), di-n-butyl phthalate (DnBP), and butylbenzyl
phthalate (BBzP) (Zota et al., 2014). In this process the old chemicals
are substituted with new chemicals with similar function. Di-iso-
nonylcyclohexane 1,2-dicarboxylate (DiNCH) was introduced in 2002
to replace DEHP and other phthalates in PVC (Gomez Ramos et al.,
2016) as it has been considered to be less toxic (SCENIHR, 2015;
ECHA, 2016).
Phenolic substances constitute a broad and heterogeneous group
including diﬀerent bisphenols used as monomers in production of
plastic and the anti-bacterial agent triclosan (Soeborg et al., 2014;
Rochester and Bolden, 2015). Some chemicals are metabolised to
phenolic compounds in the body, for instance pesticides (Nolan et al.,
1984; Heudorf and Angerer, 2001).
The aim of the present study was to investigate if measures to
decrease production and use of some of these non-persistent chemicals
have resulted in decreased human exposure, and to determine if
exposure to replacement chemicals has increased. Temporal trends
were evaluated for 13 phthalate metabolites of seven diﬀerent phtha-
lates, di-ethyl phthalate (DEP), DnBP, BBzP, DEHP, di-isononyl
phthalate (DiNP), di-iso-decyl phthalate (DiDP) and di(2-propyl hep-
tyl) phthalate (DPHP), one metabolite of DiNCH, four diﬀerent bi-
sphenols, bisphenol A (BPA), S (BPS) and F (4,4-BPF, 2,2-BPF) and
triclosan, one metabolite of the organophosphate-based ﬂame retar-
dant and plasticizer tri-phenylphosphate (TTP), and two metabolites of
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the insecticides chloropyrifos and pyretroids, in urine sampled between
2009 and 2014.
2. Materials and methods
2.1. Recruitment and sampling
Urine samples were collected from primiparous women living in
Uppsala County, Sweden, and included in the POPUP study (Persistent
Organic Pollutants in Uppsala Primiparas) conducted by the Swedish
National Food Agency. Mothers were randomly recruited among ﬁrst-
time mothers who were Swedish by birth and delivered at Uppsala
University Hospital (Glynn et al., 2007). All women had to be Swedish
by birth as previous studies have shown that levels of POPs varies if the
women were born in a Nordic country or not (Glynn et al., 2007). For
the rapidly metabolized chemicals in the present study, birth country is
probably not of great importance although there may still be life-style
diﬀerences that inﬂuence exposure. Morning spot urine samples were
sampled by the mothers themselves in a glass bottle three weeks after
delivery and the samples were thereafter biobanked at −20 °C. In total,
30 women were sampled every year between 2009 and 2014 and the
participating rate was 52%. Data on age, weight, length, lifestyle,
medical history, food habits etc. of the mothers were obtained from
questionnaires (Table 1). For details about recruitment and collection
of personal characteristics data see Glynn et al. (2007) and Lignell et al.
(2009).
2.2. Analysis
In the present study urine metabolites of DEP: mono-ethyl phtha-
late (MEP); DnBP: mono-n-butyl phthalate (MnBP); BBzP: mono-
benzyl phthalate (MBzP), and ﬁve metabolites of DEHP: mono-2-
ethylhexyl phthalate (MEHP), mono-2-ethyl-5-hydroxylhexyl phthalate
(MEHHP), mono-2-ethyl-5-oxohexyl phthalate (MEOHP), mono-2-
ethyl-5-carboxypentyl phthalate (MECPP), mono-2-carboxymethyl-
hexyl phthalate (MCMHP) were analyzed. Also three metabolites of
DiNP were analyzed: mono-hydroxy-isononyl phthalate (MHiNP),
mono-oxoisononyl phthalate (MOiNP), and mono-carboxy-isooctyl
phthalate (MCiOP), as well as two metabolites of a mix of DiDP and
DPHP: mono-carboxy-isononyl phthalate (MCiNP) and 6-hydroxy
propylheptyl phthalate (MHiDP), and the DiNCH metabolite: 2–4-
methyl-7-oxyooctyl-oxycarbonyl-cyclohexane carboxylic acid
(MOiNCH). In total ﬁve phenols were analyzed: triclosan and four
diﬀerent bisphenols (BPA, BPS, 4,4-BPF, and 2,2-BPF). One metabolite
of TPP: di-phenyl phosphate (DPP), and two metabolites of chloropyr-
ifos and pyretroids: trichloropyridinol (TCP) and 3-phenoxybencoic
acid (3-PBA) respectively, were analyzed.
Samples were analysed by a modiﬁed method for phthalate
metabolites using liquid chromatography tandem mass spectromery
(Bornehag et al., 2015). Brieﬂy, urine were added with ammonium
acetate and glucoronidase (E-coli) and thereafter incubated at 37°.
Then a 50:50 (v:v) water and acetonitrile solution of labelled (3H or
13C) internal standards (IS) of all analysed compounds were added.
The samples were analysed in duplicate and all samples were analysed
in a randomised order. For quality control of the analyses, chemical
blanks and in-house prepared quality control samples were analysed in
all sample batches. The limit of detection (LOD) was deﬁned as the
concentration corresponding to a peak area ratio of three times the
standard deviation of the chemical blanks and is shown in Table 2.
Furthermore, the imprecisions of the method is shown in Table 2,
reported as the coeﬃcient of variation of the quality control sample.
The laboratory at Lund University is a reference laboratory for analyses
of urinary phthalate metabolites and bisphenol A in a European
biomonitoring project (www.eu-hbm.info/cophes). Moreover, the
laboratory participates in the Erlangen inter-laboratory comparison
program for those compounds where this is possible. Density adjusted
urine concentrations were calculated according to Carnerup et al.
(2006).
2.3. Calculations and statistics
A total of 178 women were included in the data set. When urine
concentrations were below LOD, reported concentrations were used
where the blank concentrations were subtracted from the measured
concentration of the sample. In the case were the results were zero or
negative, the concentration were set to the lowest measured concen-
Table 1
Characteristics of the participating first-time mothers from Uppsala, Sweden sampled in
2009–2014 (n=178).
Variable N Mean Median Range
Age of the mother (year) 178 29.6 29.7 20–41
Pre-pregnancy body mass index (BMI, kg/
m2)
178 23.4 22.7 17–40
Weight gain during pregnancy (% of initial
weight)
178 23.8 23.2 −5.9–49
Weight reduction from delivery to sampling
(%)a
178 9.1 9.0 1.3–25
Variable N %
Education max 3–4 yr high school 33 19
–3 yr higher education 40 22
> 3 yr higher education 105 59
Smokingb Non-smoker 103 58
Former smoker 39 22
Smoker 36 20
Seasonc Winter 37 21
Spring 51 29
Summer 24 13
Autumn 66 37
a Weight reduction minus birth weight of the child in % of weight just before delivery.
b Women who stopped smoking before pregnancy are considered to be former
smokers. Women who smoked during pregnancy, even if they stopped smoking during
the ﬁrst or second month of pregnancy, are considered to be smokers.
c Time of the year for sampling. Winter=Dec–Feb; Spring=Mar–May; Summer=June–
Aug; Autumn=Sept–Nov.
Table 2
Limit of detection (LOD) and the coefficient of variation (CV) for all substances.
Name Abbreviation LOD
(ng/ml)
CV (%)
Monoethyl phthalate MEP 0.3 10
Mono-n-butyl phthalate MnBP 1.6 7
Monobenzyl phthalate MBzP 0.2 7
Mono-(2-ethylhexyl) phthalate MEHP 5.0 19
Mono-(2-ethyl-5-hydroxylhexyl)
phthalate
MEHHP 0.1 11
Mono-(2-ethyl-5-oxohexyl) phthalate MEOHP 0.2 7
Mono-(2-ethyl-5-carboxypentyl)
phthalate
MECPP 0.07 5
Mono-(2-carboxymethyl-hexyl) phthalate MCMHP 0.05 5
Monohydroxyisononyl phthalate MHiNP 0.05 7
Monooxoisononylphthalate MOiNP 0.05 4
Monocarboxyisooctyl phthalate MCiOP 0.05 5
Monocarboxyisononyl phthalate MCiNP 0.05 4
6-Hydroxypropylheptyl phthalate MHiDP 0.08 9
2-4-Methyl-7-oxyooctyl-oxycarbonyl-
cyclohexanecarboxylic acid
MOiNCH 0.08 6
Triclosan 0.10 9
Bisphenol A BPA 0.22 3
Bisphenol S BPS 0.03 4
4,4-Bisphenol F 4,4-BPF 0.03 6
2,2-Bisphenol F 2,2-BPF 0.01 3
Di-phenylphosphate DPP 0.03 10
Trichloropyridinol TCP 0.02 2
3-Phenoxybencoic acid 3-PBA 0.03 3
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tration ( < LOD) for each substances. The use of determined values
below LOD will result in less statistical bias than if concentration below
LOD are replaced with for instance zero, ½ LOD or LOD/√2, since the
latter replacements will introduce a systematic error (RSC, 2001;
Bergstrand and Karlsson, 2009).
Temporal trends were investigated for the study period 2009–2014.
Multiple linear regressions (MINITAB 15® Statistical Software for
Windows) were used to analyze associations between logarithmically-
transformed and density-adjusted urine concentrations and sampling
year. Logarithmically-transformed data were used since the distribu-
tion of data closely followed a log-normal distribution. Covariates in
the multiple linear regression models were age of the women, pre-
pregnancy body-mass-index (BMI), weight gain during pregnancy,
weight loss from delivery to time of sampling, education, and season
of sampling. These covariates were used as they were signiﬁcantly
associated with urine concentrations of one or more of the analyzed
substances in univariate models. Smoking was not signiﬁcantly asso-
ciated with urine concentrations of any substance and was therefore
not included as a covariate. Women who smoked during pregnancy
were considered to be smokers even if they stopped smoking during the
ﬁrst or second month of pregnancy. The urine samples were taken 3
weeks after delivery when probably a very limited number of the
women smoked. A sensitivity test was performed where observations
with standardized residuals≥3 were excluded from analysis due to their
large inﬂuence on the regression results. The statistical signiﬁcance was
set to p≤0.05. The associations between urine concentrations and
sampling year are presented as percent change of concentration per
year: % change=(1−exp(b)) x100, where b is the regression coeﬃcient
for the variable ‘‘sampling year”.
3. Results
Urine concentrations of all analysed substances are presented as
ng/ml and as density-adjusted concentrations in Table 3. MEP, MnBP,
and MCiOP were found at highest concentration in urine and BPS, 3-
PBA and 2,2-BPF at the lowest (Table 3).
3.1. Temporal trends
Signiﬁcantly negative temporal trends were seen for MEP, MnBP,
and MBzP, metabolites of DEP, DnBP, and BBzP, respectively, and four
out of ﬁve metabolites of DEHP: MEHHP, MEOHP, MECPP, and
MCMHP (Table 4). For the three metabolites to DiNP: MHiNP,
MOiNP, and MCiOP no signiﬁcant trend was observed (Table 4).
Trends of the metabolites of the mix of DiDP and DPHP diﬀered, with
MCiNP being signiﬁcantly negative but with no signiﬁcant trend for
MHiDP. MOiNCH, the metabolite of DiNCH, showed a signiﬁcant
increasing temporal trend during the study time (Table 4, Fig. 1a).
Signiﬁcantly decreasing temporal trends were observed for urine
concentrations of triclosan and BPA, during the study period (Table 4,
Fig. 1b). During the same time 4,4-BPF showed an increasing temporal
trend (Table 4, Fig. 1c). For 3-PBA a signiﬁcantly increasing trend was
observed when outliers were excluded in the sensitivity test (Table 4).
No other statistically signiﬁcant trends were seen.
4. Discussion
4.1. Concentrations in urine
Human exposure to phthalates and phenols occurs through food
and drinking water ingestion, inhalation of air, and dermal contact with
products containing these chemicals. Human exposure to chlorpyrifos
and pyretroids is probably dominated by residues in food. The
substances in the present study are metabolised fairly rapidly in the
body and urine concentrations shows recent exposure from hours to
days.
Comparisons with results from other studies are hampered by for
instance diﬀerences in study populations, year of sampling, and the use
of diﬀerent analytical methods. Nevertheless, for phthalate metabolites
the urine concentrations in the POPUP women were in the same range
as in previous studies of Swedish women sampled during the same time
period and analysed with the same method (Jönsson et al., 2014;
Larsson et al., 2014). To our knowledge there are no published Swedish
data for MCiNP, MHiDP and MOiNCH. In the present study, urine
concentrations of DEHP metabolites and MEP were in the same range
as from women in several European studies from 2011 to 2012,
Table 3
Concentrations of phthalates and DINCH metabolites, and phenolic substances in urine (ng/ml) from first-time mothers (n=178) in Uppsala sampled 2009–2014.
Substance Parent compund <LOD (%) Unadjusted Density adjusted
Mean Median Range Mean Median Range
MEP DEP 0 58.1 24.6 2.30–1374 55.0 24.3 3.34–1063
MnBP DnBP 0 51.3 40.0 4.09–371 49.6 42.7 5.95–228
MBzP BBzP 0 12.8 8.13 3.80–190 12.7 8.76 1.09–144
MEHPa DEHP 96 (55) 5.76 < LOD < LOD−32.2 6.70 < LOD < LOD−49.4
MEHHP DEHP 0 18.0 10.8 0.73–174 16.6 11.4 1.95–126
MEOHP DEHP 0 12.7 7.45 0.78–148 11.9 7.76 1.42–80.1
MECPP DEHP 0 14.3 8.66 0.76–164 13.5 8.94 1.45–95.6
MCMHP DEHP 0 4.93 2.85 0.39–77.4 4.63 3.16 0.83–40.9
MHiNP DiNP 0 20.8 5.26 0.14–395 18.4 5.98 0.45–395
MOiNP DiNP 0 10.1 3.00 0.08–182 8.80 3.19 0.22–182
MCiOP DiNP 0 30.8 12.0 0.44–382 29.7 12.0 1.26–382
MCiNP DiDP and DPHP 2 (1) 1.51 0.58 < LOD−35.5 1.29 0.63 < LOD−21.9
MHiDP DiDP and DPHP 1 (1) 7.17 1.39 < LOD−606 5.37 1.61 < LOD−359
MOiNCH DiNCH 17 (10) 1.16 0.33 < LOD−42.2 1.13 0.37 < LOD−42.2
Triclosan 32 (18) 12.6 0.32 < LOD−732 12.2 0.32 < LOD−650
BPA 8 (4) 1.67 0.87 < LOD−15.9 1.57 1.02 < LOD−17.0
BPS 57 (32) 0.12 0.043 < LOD−1.38 0.11 0.048 < LOD−1.46
4,4-BPF 3 (2) 1.09 0.29 < LOD−24.3 1.20 0.32 < LOD−18.7
2,2-BPF 59 (33) 0.066 0.015 < LOD−2.66 0.064 0.017 < LOD−2.24
DPP TPP 0 1.69 0.98 0.064–35.5 1.64 1.03 0.22–35.5
TCP Chlorpyrifos 0 1.90 1.32 0.086–14.2 1.98 1.36 0.16–22.7
3-PBA Pyretroids 2 (2) 0.35 0.22 < LOD−2.59 0.36 0.23 < LOD−3.80
a n=174.
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whereas mean MnBP concentrations were about two-times lower and
MBzP about two-times higher (Den Hond et al., 2015), indicating
region-speciﬁc diﬀerences in exposure. Urine concentrations of the
metabolites of DiNP were about two to three-fold higher in the present
study compared to previous studies in adults from Germany (1988–
2008) and the U.S. (2005–2010) (Wittassek et al., 2007; Göen et al.,
2011; Zota et al., 2014). Studies of urine concentrations of MCiNP,
MHiDP and MOiNCH are scarce. Adults in the U.S. sampled 2005–
2010 had higher urine concentrations of MCiNP than the POPUP
women (Zota et al., 2014) and both MCiNP and MOiNCH concentra-
tions were higher in Australian adults (2013) than in the present study
(Gomez Ramos et al., 2016). Norweigan adults sampled 2013–2014
and German adults sampled in 2012 had urine concentrations of
MOiNCH in the same range as the present study (Schutze et al., 2014;
Giovanoulis et al., 2016).
Median concentrations of triclosan in the present study were 2.4-
times lower compared to young Swedish women sampled in 2013
(Jönsson et al., 2014) but higher compared to a previous study of
Swedish mothers sampled 2011–2012 (Larsson et al., 2014). Median
concentrations of BPA were in the same range as in young Swedish
women and about 1.3-times lower compared to Swedish mothers
(Jönsson et al., 2014; Larsson et al., 2014). Concentrations of BPA in
the present study were also lower compared to recent studies of 684
women in other European countries sampled 2008 and 2011–2012
(Covaci et al., 2015; Guidry et al., 2015). Studies of urine concentra-
tions of BPS, 2,2-BPF4, and 4-BPF are scarce. BPS, 4,4-BPF, and 2,2-
BPF have been detected at lower concentrations than in the present
study in the U.S. and China (Yang et al., 2014; Zhou et al., 2014).
DPP is a metabolite of the organophosphate ﬂame retardant and
plasticizer TPP. Previous studies from Norwegian mothers (2012) and
adults from the U.S. (2013) have shown urine concentrations of DPP in
the same range as in the present study (Van den Eede et al., 2013;
Cequier et al., 2015).
Concentrations of the metabolites of insecticides chlorpyrifos and
pyretroids, TCP and 3-PBA were similar as in a previous studies
Swedish women from 2013 (Jönsson et al., 2014). TCP concentrations
were lower compared to pregnant Norweigan women (Ye et al., 2009)
and higher compared to adults in the U. S. (Barr et al., 2005; Trunnelle
Table 4
Annual changea (% per year and standard error (SE)) in concentrations of phthalates and DINCH metabolites, and phenolic substances in urine from ﬁrst-time mothers in Uppsala,
Sweden, 2009–2014 (n=178).
Substance < LODc (%) All samples After Sensitivity testb
Mean (SE) p R2 (%)d n Mean (SE) p R2 (%)d
MEP 0 −9.8 (4.0) 0.020 11 176 −11 (3.7) 0.006 14
MnBP 0 −14 (2.1) < 0.001 24 175 −14 (1.9) < 0.001 25
MBzP 0 −16 (3.1) < 0.001 17 176 −16 (3.0) < 0.001 18
MEHPe 96 (55) 0.93 (4.9) 0.85 10 169 −1.7 (3.9) 0.67 8
MEHHP 0 −16 (2.7) < 0.001 18 176 −16 (2.6) < 0.001 19
MEOHP 0 −17 (2.7) < 0.001 20 177 −17 (2.6) < 0.001 21
MECPP 0 −16 (2.7) < 0.001 19 177 −16 (2.6) < 0.001 20
MCMHP 0 −17 (2.4) < 0.001 23 176 −16 (2.3) < 0.001 22
MHiNP 0 −3.7 (5.8) 0.52 5 177 −4.2 (5.6) 0.45 6
MOiNP 0 −1.0 (5.4) 0.85 5 177 −1.5 (5.2) 0.77 6
MCiOP 0 −5.5 (5.0) 0.28 5 178 −5.5 (5.0) 0.28 5
MCiNP 2 (1) −8.0 (4.4) 0.078 9 174 −9.6 (4.0) 0.020 8
MHiDP 1 (1) −1.5 (5.1) 0.76 9 174 −2.6 (4.5) 0.56 5
MOiNCH 17 (10) 20 (6.7) 0.001 12 173 21 (5.9) < 0.001 15
Triclosan 32 (18) −24 (6.1) 0.001 10 170 −17 (4.7) 0.001 11
BPA 8 (4) −9.8 (4.3) 0.029 11 173 −10 (3.2) 0.003 10
BPS 57 (32) −0.80 (6.2) 0.90 6 177 −1.4 (6.0) 0.82 7
4,4-BPF 3 (2) 20 (7.6) 0.003 14 176 20 (7.2) 0.002 13
2,2-BPF 59 (33) 11 (7.2) 0.095 13 176 10 (6.7) 0.10 16
DPP 0 −2.9 (3.2) 0.36 9 175 −0.38 (2.9) 0.90 8
TCP 0 −4.0 (3.6) 0.27 6 176 −5.3 (3.3) 0.12 6
3-PBA 2 (2) 3.1 (3.6) 0.38 9 173 7.9 (3.1) 0.008 17
a Multiple regression analysis was used for evaluation of associations between density adjusted urine concentrations (ln-tranformed) and sampling year, with the covariates: maternal
age, pre-pregnancy BMI, years of education, weight gain during pregnancy, weight loss after delivery, and sampling season.
b Results after sensitivity test with exclusion of outliers.
c For values below LOD, reported values were used.
d Coeﬃcient of determination for the whole regression model.
e n=174.
Fig. 1. Temporal trends of urine concentrations of a) MOiNCH, b) BPA, and c) 4,4-BPF (ng/ml) in ﬁrst-time mothers from Uppsala, Sweden, during the time period 2009–2014.
Multiple regression analysis was used for evaluation of associations between density adjusted urine concentrations (ln-tranformed) and sampling year, with the covariates: maternal age,
pre-pregnancy BMI, years of education, weight gain during pregnancy, weight loss after delivery, and sampling season.
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et al., 2014). 3-PBA concentrations were in the same range as in U. S.
adults in the NHANES study 2001–2002 (Barr et al., 2010) but lower
compared to a more recent study from California (Trunnelle et al.,
2014).
4.2. Temporal trends
Negative temporal trends were observed for metabolites of DEP,
DnBP, and BBzP, and four out of ﬁve metabolites of DEHP. For the
DEHP metabolite MEHP no temporal trend was detected. For this
metabolite 55% of the samples were below LOD and the estimation of
the temporal trend is therefore highly uncertain. The mean decreases
were estimated to range on average between 11% and 17% per year
between 2009 and 2014, which corresponds to half-times of 4–6 years.
This shows that eﬀorts to phase out production and use of these
phthalates in Europe have resulted in a signiﬁcantly decreased human
exposure in Sweden. There are restrictions on phthalates, in toys and
childcare products on the EU market (regardless of manufacturing
country) since 2006 and in food contact materials since 2011 (KEMI,
2014). The use of DEHP, DnBP and BBzP is banned in the EU since
2015 unless permission has been sought for speciﬁc purposes (KEMI,
2014), however there are no restrictions for imported goods.
MOiNCH, the metabolite of DiNCH, showed a signiﬁcant increasing
temporal trend during the study time. The mean yearly increase was
20%, corresponding to a doubling of exposure every 3.5 years. DiNCH
was introduced in 2002 as a replacement to DEHP and other high-
molecular weight phthalates in PVC (Gomez Ramos et al., 2016). In
Sweden the usage of DiNCH has been estimated to have increased
dramatically (47-fold) between 2011 and 2012 (KEMI, 2014), and our
results show that this has resulted in signiﬁcantly increased human
exposure in Sweden. Between 2009 and 2014 the adjusted mean urine
concentration increased from 0.2 to 0.7 ng/ml.
For the three metabolites of DiNP no signiﬁcant trend was seen.
Trends of the metabolites of the mix of DiDP and DPHP diﬀered, with
MCiNP being signiﬁcantly negative but with no trend for MHiDP. In
Europe DiNP, DiDP and DPHP are the most frequently used phthalates
whereas in many other countries DEHP is the dominating compound
(KEMI, 2014). Our results show that the human exposure to these
phthalates in Sweden has not changed dramatically during the study
period.
A few other studies have reported decreasing trends of metabolites
of DEP, DnBP, BBxP, and DEHP during the last decade in adults from
Sweden, Germany, and the U.S. (Wittassek et al., 2007; Göen et al.,
2011; Jönsson et al., 2014; Zota et al., 2014), showing that the
decreased exposure observed by us is an international phenomenon.
The results for metabolites of DiNP in previous studies have shown a
small increasing temporal trend in the beginning of the 21th century
(Wittassek et al., 2007; Göen et al., 2011; Zota et al., 2014). In the
present study temporal trends were studied at a later time period and
no signiﬁcant trends were seen for the three metabolites of DiNP.
MCiNP showed a decreasing temporal trend in the present study
(2009–2014) compared to an increase in U.S adults between 2005–
2006 and 2009–2010 (Zota et al., 2014). German adults sampled
between 1999 and 2012 had as in the present study an increasing trend
for MOiNCH (DiNCH) (Schutze et al., 2014). To our knowledge this is
the ﬁrst temporal trend study of the metabolite MHiDP (DiDP and
DPHP).
Signiﬁcantly decreasing temporal trends were observed for urine
concentrations of BPA during the period 2009–2014, with a half-life of
6.6 years. Interestingly 4,4-BPF showed an increasing temporal trend
during the same time period, with a doubling in mean concentrations
every 3.8 years. Declining temporal trends for BPA has also been seen
in the U.S NHANES study between 2003 and 2012 (LaKind and
Naiman, 2015) and also in young Swedish men between 2010 and 2013
(Jönsson et al., 2014). Reported urine concentrations below LOD were
used in the statistical trends analysis the present study and these data
are more uncertain than data with concentrations≥LOD. Signiﬁcant
declining trends of BPA were seen in the sensitivity analysis (exclusion
of outliers) (Table 4) and also when all values below LOD were set to
LOD/√2 (data not shown). BPA is a well-debated compound and as a
result of consumer concern the industry have begun to remove BPA
from their products (Rochester and Bolden, 2015). The use of BPA in
baby bottles and cosmetics has been banned in the EU (EC, 2009,
2011). Other bisphenols like BPS, 4,4-BPF, and 2,2-BPF are now
gradually replacing BPA (Rochester and Bolden, 2015) and our study
show that exposure to at least 4,4-BPF is increasing. Toxicological data
on BPS and BPF are scarce but there are studies suggesting that the
eﬀects might be similar to those of BPA (Eladak et al., 2015). To our
knowledge this is the ﬁrst study of temporal trends for BPS, 2,2-BPF,
and 4,4-BPF.
In the present study decreasing urine concentrations of triclosan
were found during the study period (Table 4) as also seen in previous
studies from the U.S. (Mortensen et al., 2014; Han et al., 2016). The
declining trend is probably because of declining use, as triclosan have
been regulated during the last years. In the EU triclosan has been
regulated in cosmetic products since 2014 (EC, 2014) and since 2016
triclosan was not allowed to be used as a biocide in all types of products
(product type 1) except cosmetics (EC, 2016). The U.S Food and Drug
Administration (FDU) have recently decided that triclosan in antiseptic
wash products for consumer will not be allowed on the market from
September 2017 (FDU, 2016).
Exposure to the ﬂame retardant and plasticizer TTP did not change
markedly between 2009 and 2012, since no signiﬁcant temporal trend
were shown for the metabolite. Similarly we observed no trend for the
pesticide metabolite TCP. Urine concentrations of 3-PBA, the metabo-
lite to pyretroids, had a signiﬁcant increasing temporal trend after
exclusion of outliers (Table 4). Thus, our data suggest that exposure to
pyretroids have increased in Sweden between 2009 and 2015. To our
knowledge no well-designed temporal trend studies have previously
been published for 3-PBA, TCP or DPP. In adults in the U.S (NHANES)
no diﬀerences were seen in 3-PBA concentrations between 1999–2000
and 2001–2002 (Barr et al., 2010).
4.3. Strengths and limitations
In the present study a single spot urine sample was taken from the
participating women. The substances included in our study are rapidly
metabolised and excreted into urine, and therefore individual concen-
trations of metabolites show both diurnal and weekly variation. Spot
urine samples make it therefore more diﬃcult to discover temporal
trends. However, we could anyway observe temporal trends for some of
the compounds mainly due to the facts that the ﬁrst-time mothers from
Uppsala is a homogenous population and the temporal trends were
adjusted for several life-style/medical factors that could confound the
results. Nevertheless, the use of spot samples and the relatively short
study period also makes it possible that there are some trends that we
could not detect.
The changes in exposure that we observed could be due to changes
in life-style, for which we did not have data on, rather than changes in
use and production by the industry. However, the present study had a
relatively short study period of six years and it is not likely with
dramatic life-style changes during such a short period. This study
showed results from a population of young women in only one region
and there might be regional diﬀerences in exposure. For example urine
concentrations of MnBP och MBzP was higher in urine from adults
living in the northern part of Sweden than among those living in the
southern parts (Bjermo et al., 2013). Furthermore, diﬀerences in
exposure have been observed between populations living on the
countryside and in urban areas (Larsson et al., 2014).
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5. Conclusion
Urine concentration of metabolites of phthalates, which are in the
process of being phased out, such as DEP, DnBP, BBzP, and DEHP,
showed declining temporal trends in ﬁrst time mothers from Uppsala,
Sweden, 2009–2014. During the same period the concentrations of the
metabolite of the replacement plasticizer DiNCH increased. Also the
much debated phenolic substances triclosan and BPA showed a
decreasing temporal trend, while 4,4-BPF, a replacement for BPA,
increased. Most likely, reduced production and use of certain endo-
crine-active chemicals have resulted in decreased human exposures. At
the same time exposures to some of the replacement chemicals have
increased, which may become a problem in the future if the increase
continues. Our results show that policy decisions and other external
pressure on the industry to phase-out certain problematic chemicals
may drive chemical substitution in diﬀerent directions depending on
the availability of alternative chemicals. On one hand, the phase-out of
potentially toxic phthalates, such as DEHP, DnBP and BBzP, have
resulted in substitution with the apparently less toxic non-phthalate
plasticizer DiNCH. On the other hand, replacement of the well-studied
BPA with the less studied BPF, as BPA a possible EDC, may not be
beneﬁcial from a human health risk point-of-view. A more structured
and scientiﬁcally sound policy, regulating the process of chemical
substitution, is needed for a long-term sustainable chemical production
and use world-wide. Moreover, even less problematic chemicals may be
harmful to health if exposure is high enough. Therefore it is of vital
importance to continue to follow the trends of human exposure to
newly introduced chemicals.
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